Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times Netherlands.
Press releases published on April 1, 2025

Quorum Software Launches Global Partner Advantage Program
Empowering Collaboration and Accelerating Partner Success HOUSTON, TX, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Quorum Software, a global leader in energy software, today announced the launch of the Quorum Partner Advantage Program, a …

Transaction in Own Shares
Transaction in Own Shares 01 April, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 01 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

Director/PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU AND UK MARKET ABUSE REGIMES 1. Details of the person discharging managerial responsibilities/person closely …

Stellantis Annual General Meeting Live Webcast Available
Stellantis Annual General Meeting Live Webcast Available AMSTERDAM, April 1, 2025 – Stellantis N.V. announced today that a link for the live webcast of its Annual General Meeting for the approval of Stellantis N.V.’s 2024 financial statements will be made …

Progress on share buyback programme
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 2,754,057 shares were repurchased during the week of 24 March 2025 up to and including 28 March 2025. …

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights
Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock and extended cash runway for two years Gained exclusive rights to premier brain-computer interface technology EINDHOVEN, The …

ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025
Obtention de l’autorisation de la FDA et premières ventes commerciales du système ARC-EX Investissement stratégique d’Ottobock et extension de la visibilité financière sur deux ans Obtention de droits exclusifs sur une technologie de pointe d’interface …